Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000899140-19-000618
Filing Date
2019-11-19
Accepted
2019-11-19 16:42:47
Documents
2
Group Members
CUBIST SYSTEMATIC STRATEGIES, LLCPOINT72 CAPITAL ADVISORS, INC.STEVEN A. COHEN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G p32052555a.htm SC 13G 55993
2 JOINT FILING AGREEMENT p32052555b.htm EX-99.1 3287
  Complete submission text file 0000899140-19-000618.txt   60915
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Subject) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-44055 | Film No.: 191231797
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902
Business Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902 203-890-2000
Point72 Asset Management, L.P. (Filed by) CIK: 0001603466 (see all company filings)

EIN.: 465064661 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G